Elevance Health, Inc. (ELV) Insider Transactions
Over the last 12 months, 19 Elevance Health, Inc. (ELV) insiders filed 73 SEC Form 4 transactions — $3.7M in open-market purchases ( 3 distinct buyers) and $1.6M in open-market sales. 0% of all transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.
- $3.7MOpen-market buys (1y)
- $1.6MOpen-market sells (1y)
- 19Distinct insiders
- 73Transactions filed
- 0%Under Rule 10b5-1 plan
- 2026-06-11Latest filing
Recent Form 4 Filings Most recent 50 of 73 (1-year window)
Each row is a single Form 4 filing event for ELV, sourced directly from SEC EDGAR. The Type column classifies the SEC transaction code into Buy / Sell / Grant / Exercise / Other; the 10b5-1 badge marks trades executed under a pre-scheduled SEC Rule 10b5-1 plan.
| Date | Insider | Title | Type | SEC Code | Value | Shares | Price |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | Dixon Robert L JR | — | Sell | S | $60.7K | 151 | $401.77 |
| 2026-05-19 | Penczek Ronald W | CAO & Controller | Exercise | M | $177.4K | 654 | $271.27 |
| 2026-05-19 | Penczek Ronald W | CAO & Controller | Exercise | M | $273.2K | 877 | $311.48 |
| 2026-05-19 | Penczek Ronald W | CAO & Controller | Exercise | M | $0 | 654 | $0.00 |
| 2026-05-19 | Penczek Ronald W | CAO & Controller | Exercise | M | $0 | 877 | $0.00 |
| 2026-05-19 | Penczek Ronald W | CAO & Controller | Sell | S | $617.2K | 1,531 | $403.13 |
| 2026-05-13 | STRABLE-SOETHOUT DEANNA D | — | Grant | A | $0 | 563 | $0.00 |
| 2026-05-13 | SCHULMAN AMY W | — | Grant | A | $0 | 563 | $0.00 |
| 2026-05-13 | Schneider Ryan M. | — | Grant | A | $0 | 563 | $0.00 |
| 2026-05-13 | PERU RAMIRO G | — | Grant | A | $0 | 563 | $0.00 |
| 2026-05-13 | Neri Antonio F | — | Grant | A | $0 | 563 | $0.00 |
| 2026-05-13 | Jallal Bahija | — | Grant | A | $0 | 563 | $0.00 |
| 2026-05-13 | HAY LEWIS III | — | Grant | A | $0 | 563 | $0.00 |
| 2026-05-13 | Dixon Robert L JR | — | Grant | A | $0 | 563 | $0.00 |
| 2026-05-13 | DeVore Susan D. | — | Grant | A | $0 | 563 | $0.00 |
| 2026-05-13 | COLLIS STEVEN H | — | Grant | A | $0 | 563 | $0.00 |
| 2026-03-12 | SCHULMAN AMY W | — | Sell | — | $7.5K | 26 | $287.50 |
| 2026-03-06 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | — | $910.6K | 3,196 | $284.92 |
| 2026-03-05 | COLLIS STEVEN H | — | Buy | — | $869.5K | 3,000 | $289.84 |
| 2026-03-03 | Penczek Ronald W | CAO & Controller | Grant | — | $10.5K | 37 | $284.03 |
| 2026-03-03 | Wessling Erin M | EVP & Chief Legal Officer | Grant | — | $118.4K | 417 | $284.03 |
| 2026-03-03 | Craig Ryan R | EVP & Chief HR Officer | Grant | — | $87.8K | 309 | $284.03 |
| 2026-03-03 | Norwood Felicia F | EVP &Chief Health Benefits Ofr | Grant | — | $140.9K | 496 | $284.03 |
| 2026-03-03 | LAVU RATNAKAR | EVP & Chief Digital Info Ofr | Grant | — | $63.1K | 222 | $284.03 |
| 2026-03-03 | Kendrick Charles Morgan JR | EVP & President, Commercial | Grant | — | $132.6K | 467 | $284.03 |
| 2026-03-03 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Grant | — | $126.7K | 446 | $284.03 |
| 2026-03-03 | Kaye Mark | EVP & CFO | Grant | — | $100.3K | 353 | $284.03 |
| 2026-03-03 | BOUDREAUX GAIL | President and CEO | Grant | — | $493.1K | 1,736 | $284.03 |
| 2026-03-02 | Penczek Ronald W | CAO & Controller | Grant | — | $38.5K | 131 | $294.07 |
| 2026-03-02 | Penczek Ronald W | CAO & Controller | Grant | — | $0 | 426 | $0.00 |
| 2026-03-02 | Penczek Ronald W | CAO & Controller | Grant | — | $0 | 1,701 | $0.00 |
| 2026-03-02 | Penczek Ronald W | CAO & Controller | Grant | — | $0 | 266 | $0.00 |
| 2026-03-02 | Penczek Ronald W | CAO & Controller | Grant | — | $0 | 1,677 | $0.00 |
| 2026-03-02 | Wessling Erin M | EVP & Chief Legal Officer | Grant | — | $0 | 2,976 | $0.00 |
| 2026-03-02 | Wessling Erin M | EVP & Chief Legal Officer | Grant | — | $0 | 11,754 | $0.00 |
| 2026-03-02 | Craig Ryan R | EVP & Chief HR Officer | Grant | — | $7.4K | 25 | $294.07 |
| 2026-03-02 | Craig Ryan R | EVP & Chief HR Officer | Grant | — | $0 | 2,976 | $0.00 |
| 2026-03-02 | Craig Ryan R | EVP & Chief HR Officer | Grant | — | $0 | 11,754 | $0.00 |
| 2026-03-02 | Norwood Felicia F | EVP &Chief Health Benefits Ofr | Grant | — | $417.9K | 1,421 | $294.07 |
| 2026-03-02 | Norwood Felicia F | EVP &Chief Health Benefits Ofr | Grant | — | $0 | 5,951 | $0.00 |
| 2026-03-02 | Norwood Felicia F | EVP &Chief Health Benefits Ofr | Grant | — | $0 | 2,865 | $0.00 |
| 2026-03-02 | Norwood Felicia F | EVP &Chief Health Benefits Ofr | Grant | — | $0 | 23,512 | $0.00 |
| 2026-03-02 | LAVU RATNAKAR | EVP & Chief Digital Info Ofr | Grant | — | $92.6K | 315 | $294.07 |
| 2026-03-02 | LAVU RATNAKAR | EVP & Chief Digital Info Ofr | Grant | — | $0 | 5,101 | $0.00 |
| 2026-03-02 | LAVU RATNAKAR | EVP & Chief Digital Info Ofr | Grant | — | $0 | 6,802 | $0.00 |
| 2026-03-02 | LAVU RATNAKAR | EVP & Chief Digital Info Ofr | Grant | — | $0 | 20,152 | $0.00 |
| 2026-03-02 | Kendrick Charles Morgan JR | EVP & President, Commercial | Grant | — | $356.1K | 1,211 | $294.07 |
| 2026-03-02 | Kendrick Charles Morgan JR | EVP & President, Commercial | Grant | — | $0 | 4,017 | $0.00 |
| 2026-03-02 | Kendrick Charles Morgan JR | EVP & President, Commercial | Grant | — | $0 | 2,532 | $0.00 |
| 2026-03-02 | Kendrick Charles Morgan JR | EVP & President, Commercial | Grant | — | $0 | 15,870 | $0.00 |
Showing the most recent 50 of 73 transactions. For the full 1-year history with sorting, filtering, and cross-ticker industry context, open the full insider transactions drilldown.
Top Insider Buyers of ELV By dollar volume, 1-year window
- BOUDREAUX GAIL $2.4M
- COLLIS STEVEN H $869.5K
- DeVore Susan D. $374.6K
Methodology & FAQ
How We Track ELV Insider Transactions
Form 4 disclosures are sourced directly from SEC EDGAR and re-ingested on every pipeline cycle. A complete description of transaction-code handling, the open-market vs grant distinction, and the Rule 10b5-1 plan-reference heuristic is documented in the Methodology.
What is an SEC Form 4 filing for Elevance Health, Inc.?
Form 4 is a transaction-level disclosure that corporate insiders — officers, directors, and beneficial owners of more than 10% of a registered class of equity securities — must file with the SEC within two business days of any change in their beneficial ownership of Elevance Health, Inc. (ELV) shares.
What is a Rule 10b5-1 trading plan?
Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Form 4 rows marked "10b5-1" on this page indicate the underlying trade was executed under such a plan; rows without the badge are discretionary or did not reference a plan in the Form 4 footnotes.
How is "insider buying" different from a stock grant or option exercise?
An insider buy (SEC transaction code P) is an open-market purchase of Elevance Health, Inc. (ELV) stock executed at the prevailing market price using the insider's personal capital. Stock grants (code A) and option exercises (code M) are compensation events, not directional trades; they are tracked separately and excluded from the "conviction" signal because they are not discretionary purchases.
How recent is the data?
Form 4 transactions are typically reported within two business days of execution. Pactolio re-ingests the EDGAR feed on a nightly cycle and reflects new filings on the next ingest run, typically within 24 hours of EDGAR acceptance. The table on this page covers the most recent 1-year window.